News

KATHMANDU, May 30: The government has announced its total expenditure plan of Rs 1.964 trillion for the fiscal year 2025/26, ...
With the budget scheduled for Thursday and the house in possible deadlock, the house speaker, Deb Raj Ghimire, held discussions with leaders from both the ruling and opposition parties in his chamber ...
After months of political meddling, the government has appointed Biswo Nath Poudel as the 18th Governor of Nepal Rastra Bank ...
Panellists include Ghanshyam Upadhyay, secretary at the Ministry of Finance; Rameshore Khanal, former finance secretary; Chandra Prasad Dhakal ... finance minister”, will feature Finance Minister ...
Parbat has two strong UML factions—one led by former National Assembly chairperson Ganesh Prasad Timilsina and the other by former ... During the provincial convention in 2023, party vice-chair Bishnu ...
Says Krishna Khanal, assistant professor of business ethics at King ... Him Electronics of Shekhar Golchha, Morang Auto Works of Bishnu Agarwal, Sulabh Agarwal’s Jagdamba Steels, United Builders of ...
President Droupadi Murmu hhas given sanction for the prosecution of former Railway Minister Lalu Prasad in the case alleging money laundering related to the ‘Land for Jobs scam’, according to ...
The U.S. FDA has appointed Vinay Prasad to be the next director of its Center for Biologics Evaluation and Research division (CBER), the agency's Commissioner Martin Makary posted on the social ...
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and ...
The US Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized COVID-19 restrictions, as the director of its Center for Biologics Evaluation and Research ...
05. Matthew Herper covers medical innovation — both its promise and its perils. WASHINGTON — Vinay Prasad, an academic and fierce critic of the medical mainstream, will be the next director ...
The U.S. Food and Drug Administration has tapped Dr. Vinay Prasad, an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center for Biologics ...